Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes.
Lorelei D HennessyMichel De LangeEsko J WiltshireCraig A JefferiesBenjamin John WheelerPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
In New Zealand, Māori and Pasifika, as well as youth, are over-represented in the cessation of CSII in comparison with Europeans and all other age groups. These groups are also less likely to gain initial access to public funding. Efforts to understand and reduce these disparities are needed, including review of current public funding access criteria.